Health services data protection · 4 minute read

Research Without the Red Tape: How the DUAA Transforms Data Repurposing in Healthcare

The DUAA gives medical research uses of patient data clearer footing, but the common law duty of confidence and the commercial limits still bite. Know where research ends and repurposing begins.

Translucent glass structures refracting daylight into branching architectural passages
Illustrative image

Private healthcare providers, clinics and medical research organisations have long faced a frustrating regulatory wall when attempting to repurpose patient data. For years, routine analytics, clinical audits and vital medical trials had to navigate overlapping consent chains in order to advance scientific understanding or improve patient outcomes.

The Data (Use and Access) Act 2025 received Royal Assent on 19 June 2025 and its data protection provisions are now fully in force. By streamlining the rules around data reuse, the DUAA creates clearer, workable pathways for medical research and trials, offering substantial benefits for healthcare providers looking to innovate without falling foul of data protection laws.

What the DUAA changes for research

Under the updated framework there is clearer statutory footing for processing personal data for scientific research. The Act confirms what counts as scientific research, including commercial research, fundamental or applied research and public health research conducted in the public interest. It also recognises that scientific investigations cannot always map out every analytical step in advance. Where appropriate safeguards are in place, healthcare providers and research partners can repurpose existing patient datasets for valid scientific research, public health studies and clinical trials with much greater legal certainty.

The Act also recognises broad consent, so a patient can agree to an area of scientific research rather than each individual study. Consent still has to be genuine, and a withdrawal needs careful handling. Around consent, the research provisions give researchers further room: the purpose limitation principle allows existing data to be reused for research purposes with appropriate safeguards, storage limitation allows research data to be kept for longer than ordinary processing and there is a specific research condition for special category data such as health records, where the research is in the public interest and appropriate safeguards apply.

The limits of the DUAA

This legislative relaxation is bound to genuine scientific and medical research. The DUAA does not give healthcare providers a licence to repurpose confidential patient records for routine commercial gain. Using medical histories for internal business analytics, operational benchmarking, commercial product development or direct marketing needs its own lawful basis and, for health data, an applicable special category condition. It will rarely be permitted without specific consent or a clear statutory gateway.

Health data also carries the usual requirements. A provider relying on the research condition must still document the lawful basis, the special category condition and the safeguards it applies, and transparency obligations towards patients do not fall away simply because the processing is for research.

The common law duty of confidence

Academic institutions and NHS bodies carrying out research have a common law duty of confidentiality, separate from the data protection provisions set down in the UK GDPR and the DUAA. Satisfying one does not mean compliance with the other: both frameworks need to be considered in parallel. Private clinics and research partners should apply the same thinking to any research use of their patient records, including the confidential information that leaves the practice under a research agreement.

How Loopol can help

Navigating the boundary between permitted medical research under the DUAA and commercial repurposing requires precision. Misjudging this distinction exposes healthcare providers to regulatory penalties and reputational damage. At Loopol, we provide thorough and flexible compliance frameworks tailored to how your practice works. We can audit your data flows, put clear processes around research and secondary uses of patient data and document the lawful bases, conditions and safeguards that apply.

Buy the privacy governance service below or contact Loopol to discuss your research and secondary-use plans. Audits, assessments and ongoing support are agreed separately.

Tailored to your business

Put the right health data safeguards in place

Privacy Governance and Policy Customisation: £1,850

We implement your data protection framework with you: appropriate policy document, retention schedule and IT security policies fitted to how you work. Wider assessments and ongoing support are agreed separately. No VAT is added while Loopol is not VAT registered.

Contact Loopol

helloloopol@gmail.com

A clear starting point

Request your free data protection health check

Share your website privacy policy, cookie banner details and online terms for a focused preliminary review. Receive a confidential report reviewed by Loopol within twenty-four hours. This is not a full clinical records audit.

Request my free data protection health check

Get in touch about your patient data

Tell us how your practice handles patient records and what concerns you. Loopol can help with audits, tailored policies, lawful basis reviews and ongoing support. Please do not send identifiable patient records or clinical details in your initial enquiry.

Selected: Data protection services
All articles